|
|
Volumn 9, Issue 3, 2010, Pages 440-449
|
|
The promise of novel androgen receptor antagonists
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
ANDROGEN RECEPTOR;
ANTIANDROGEN;
BICALUTAMIDE;
FLUTAMIDE;
GONADORELIN AGONIST;
PROSTATE SPECIFIC ANTIGEN;
ANDROGEN DEFICIENCY;
ANDROGEN DEPRIVATION THERAPY;
ANDROGEN METABOLISM;
ANDROGEN SYNTHESIS;
CANCER CELL CULTURE;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER SURGERY;
CANCER SURVIVAL;
CASTRATION;
DRUG TARGETING;
GENE OVEREXPRESSION;
GENE TARGETING;
GENETIC TRANSCRIPTION;
HORMONAL THERAPY;
HORMONE ACTION;
HUMAN;
LIGAND BINDING;
NOTE;
PROGNOSIS;
PROMOTER REGION;
PROSTATE CANCER;
REPORTER GENE;
SIGNAL TRANSDUCTION;
ANIMAL;
DNA RESPONSIVE ELEMENT;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG RESISTANCE;
DRUG SCREENING;
GENE EXPRESSION REGULATION;
GENETICS;
MALE;
PROSTATE TUMOR;
TUMOR CELL LINE;
ANDROGEN ANTAGONISTS;
ANIMALS;
CELL LINE, TUMOR;
DRUG RESISTANCE, NEOPLASM;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
RECEPTORS, ANDROGEN;
RESPONSE ELEMENTS;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
|
EID: 77951903529
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.9.3.11045 Document Type: Note |
|
Times cited : (10)
|
|
References (11)
|
